Pharmaceutical Technology
MAY 22, 2023
The new good manufacturing practices facility was established with support from the Singapore Economic Development Board. It comes with quick vaccine fill-finish capabilities and offers end-to-end pharmaceutical development and manufacturing services. The bioprocess design centre offers expertise in bioprocessing and process scale-up.
Delveinsight
FEBRUARY 25, 2021
Beam Therapeutics has taken over a startup whose technology could proffer the biotech’s genetic medicines to more tissues in the body, widening the potential to approach more diseases. Cambridge, Massachusetts-based Beam aims to make more precise edits with genetic medicines, which employ base-editing.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Pharma Data
SEPTEMBER 3, 2020
Our new study offers an important basis from which to start developing new treatment strategies for a rare form of cancer, which starts in the hormone-producing cells of the pancreas,” noted Dr Anguraj Sadanandam, team leader in Systems and Precision Cancer Medicine at The ICR, London. “We
Drug Discovery World
MARCH 2, 2023
DDW’s Diana Spencer reports on the recent Avacta Therapeutics Science Day, which explored the latest exciting developments in targeted treatments for cancer and asked what advances the future might bring. She explained the mechanism by which AVA6000 can provide more precise treatment than current chemotherapies.
pharmaphorum
NOVEMBER 16, 2022
It’s one of the most common causes of blindness across Europe and across the United States, and many developed countries around the world. That’s why there’s a lot of interest around this particular molecule and around this development programme.”. When we do that, we call it a perilesional analysis. About the interviewee.
The Pharma Data
JANUARY 7, 2021
In doing so, dozens more risk factors that could better help pinpoint the odds of developing prostate cancer have been uncovered. The study — described as the most diverse genetic analysis for prostate cancer ever — included men of African, Asian, Hispanic and European ancestry. Known variations now number 269.
Drug Discovery World
FEBRUARY 28, 2023
Three hundred and fifty million people in the world, with 37 million in the United States and Canada, have been diagnosed with rare disease, 80% of which are inherited and genetic in origin 2.
Expert insights. Personalized for you.
147 
Let's personalize your content